Echo Therapeutics Announces 2012 Financial Results

Published: Mar 18, 2013

PHILADELPHIA, March 18, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. , a company developing its needle-free Symphony((R)) CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced financial results for the year ended December 31, 2012. Echo's Annual Report on Form 10-K, as filed with the SEC, will be available by visiting the Investors section of Echo's website at

Back to news